These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28550666)

  • 21. Role of ground-glass opacity in pure invasive and lepidic component in pure solid lung adenocarcinoma for predicting aggressiveness.
    Mimae T; Miyata Y; Tsutani Y; Shimada Y; Ito H; Nakayama H; Ikeda N; Okada M
    JTCVS Open; 2022 Sep; 11():300-316. PubMed ID: 36172403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ground-glass opacity nodules: histopathology, imaging evaluation, and clinical implications.
    Lee HY; Lee KS
    J Thorac Imaging; 2011 May; 26(2):106-18. PubMed ID: 21508733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular markers and changes of computed tomography appearance in lung adenocarcinoma with ground-glass opacity.
    Yoshida Y; Kokubu A; Suzuki K; Kuribayashi H; Tsuta K; Matsuno Y; Kusumoto M; Kanai Y; Asamura H; Hirohashi S; Shibata T
    Jpn J Clin Oncol; 2007 Dec; 37(12):907-12. PubMed ID: 18089646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of ground-glass opacity found in small lung adenocarcinoma on high-resolution CT scanning.
    Kodama K; Higashiyama M; Yokouchi H; Takami K; Kuriyama K; Mano M; Nakayama T
    Lung Cancer; 2001 Jul; 33(1):17-25. PubMed ID: 11429192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidermal growth factor receptor mutation status in stage I lung adenocarcinoma with different image patterns.
    Hsu KH; Chen KC; Yang TY; Yeh YC; Chou TY; Chen HY; Tsai CR; Chen CY; Hsu CP; Hsia JY; Chuang CY; Tsai YH; Chen KY; Huang MS; Su WC; Chen YM; Hsiung CA; Chang GC; Chen CJ; Yang PC
    J Thorac Oncol; 2011 Jun; 6(6):1066-72. PubMed ID: 21512404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Invasiveness and malignant potential of pulmonary lesions presenting as pure ground-glass opacities.
    Ichinose J; Kohno T; Fujimori S; Harano T; Suzuki S; Fujii T
    Ann Thorac Cardiovasc Surg; 2014; 20(5):347-52. PubMed ID: 24088912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive value of one-dimensional mean computed tomography value of ground-glass opacity on high-resolution images for the possibility of future change.
    Tamura M; Shimizu Y; Yamamoto T; Yoshikawa J; Hashizume Y
    J Thorac Oncol; 2014 Apr; 9(4):469-72. PubMed ID: 24736068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of Ground-Glass Opacities in the Lung Cancer Spectrum.
    Zhang Y; Fu F; Chen H
    Ann Thorac Surg; 2020 Dec; 110(6):1796-1804. PubMed ID: 32525031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation in histological subtypes with high resolution computed tomography signatures of early stage lung adenocarcinoma.
    Miao Y; Zhang J; Zou J; Zhu Q; Lv T; Song Y
    Transl Lung Cancer Res; 2017 Feb; 6(1):14-22. PubMed ID: 28331820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Percutaneous computed tomography-guided coaxial core biopsy for small pulmonary lesions with ground-glass attenuation.
    Lu CH; Hsiao CH; Chang YC; Lee JM; Shih JY; Wu LA; Yu CJ; Liu HM; Shih TT; Yang PC
    J Thorac Oncol; 2012 Jan; 7(1):143-50. PubMed ID: 22124475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of three measurements on computed tomography for the prediction of less invasiveness in patients with clinical stage I non-small cell lung cancer.
    Matsuguma H; Oki I; Nakahara R; Suzuki H; Kasai T; Kamiyama Y; Igarashi S; Mori K; Endo S; Yokoi K
    Ann Thorac Surg; 2013 Jun; 95(6):1878-84. PubMed ID: 23618519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival and risk factors for progression after resection of the dominant tumor in multifocal, lepidic-type pulmonary adenocarcinoma.
    Gao RW; Berry MF; Kunder CA; Khuong AA; Wakelee H; Neal JW; Backhus LM; Shrager JB
    J Thorac Cardiovasc Surg; 2017 Dec; 154(6):2092-2099.e2. PubMed ID: 28863952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ground-glass opacity lesions on computed tomography during postoperative surveillance for primary non-small cell lung cancer.
    Haro A; Yano T; Kohno M; Yoshida T; Okamoto T; Maehara Y
    Lung Cancer; 2012 Apr; 76(1):56-60. PubMed ID: 21945659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Pseudocavitation Sign of Lung Adenocarcinoma: A Distinguishing Feature and Imaging Biomarker of Lepidic Growth.
    Tailor TD; Schmidt RA; Eaton KD; Wood DE; Pipavath SN
    J Thorac Imaging; 2015 Sep; 30(5):308-13. PubMed ID: 26258598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between Serum Carcinoembryonic Antigen Level and Histologic Subtype in Resected Lung Adenocarcinoma.
    Tomita M; Ayabe T; Chosa E; Nakamura K
    Asian Pac J Cancer Prev; 2015; 16(9):3857-60. PubMed ID: 25987049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of the IASLC/ATS/ERS classification in pN0 pulmonary adenocarcinomas: a study with radiological-pathological comparisons and survival analyses.
    Ambrosini-Spaltro A; Ruiu A; Seebacher C; Vattemi E; Gentile L; Feil B; Zaraca F; Carella R
    Pathol Res Pract; 2014 Jan; 210(1):40-6. PubMed ID: 24211161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic Impact of the Findings on Thin-Section Computed Tomography in Patients with Subcentimeter Non-Small Cell Lung Cancer.
    Hattori A; Matsunaga T; Hayashi T; Takamochi K; Oh S; Suzuki K
    J Thorac Oncol; 2017 Jun; 12(6):954-962. PubMed ID: 28257958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Impact of the Histologic Lepidic Component in Pathologic Stage IA Adenocarcinoma.
    Okubo Y; Kashima J; Teishikata T; Muraoka Y; Yotsukura M; Yoshida Y; Nakagawa K; Watanabe H; Kusumoto M; Watanabe SI; Yatabe Y
    J Thorac Oncol; 2022 Jan; 17(1):67-75. PubMed ID: 34634451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Value of integrated positron emission tomography revised using a phantom study to evaluate malignancy grade of lung adenocarcinoma: a multicenter study.
    Nakayama H; Okumura S; Daisaki H; Kato Y; Uehara H; Adachi S; Yoshimura M; Okada M
    Cancer; 2010 Jul; 116(13):3170-7. PubMed ID: 20564630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapidly growing small peripheral lung cancers detected by screening CT: correlation between radiological appearance and pathological features.
    Wang JC; Sone S; Feng L; Yang ZG; Takashima S; Maruyama Y; Hasegawa M; Kawakami S; Honda T; Yamanda T
    Br J Radiol; 2000 Sep; 73(873):930-7. PubMed ID: 11064644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.